stage iva squamous cell carcinoma of the oropharynx

Showing 1 - 21 of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the

Active, not recruiting
  • Human Papilloma Virus Infection
  • +3 more
  • paclitaxel albumin-stabilized nanoparticle formulation
  • +8 more
  • Chicago, Illinois
    University of Chicago
Mar 2, 2022

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • cetuximab
  • +3 more
  • Newark, New Jersey
    New Jersey Medical School
Apr 19, 2021

Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage I Squamous Cell Carcinoma of the Oropharynx, Stage I Verrucous

Completed
  • Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +18 more
  • BRB Lozenge
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 18, 2020

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +57 more
  • placebo
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 18, 2020

Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the

Completed
  • Human Papilloma Virus Infection
  • +15 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Aug 10, 2018

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +36 more
  • sorafenib tosylate
  • +3 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
May 22, 2018

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Terminated
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +45 more
  • talactoferrin
  • laboratory biomarker analysis
  • Stanford, California
    Stanford University
Jul 30, 2016

Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent

Withdrawn
  • Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +20 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Apr 19, 2016

Decisions in Patients With Stage I-IVA Oropharyngeal Cancer

Terminated
  • Stage I Squamous Cell Carcinoma of the Oropharynx
  • +4 more
  • questionnaire administration
  • quality-of-life assessment
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 1, 2015

Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Tongue Cancer Trial in

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Oropharynx
  • +2 more
  • therapeutic conventional surgery
  • +4 more
  • Stanford, California
    Stanford University Hospitals and Clinics
Mar 18, 2015

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 17, 2014

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Stage III Squamous Cell Carcinoma of the

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +26 more
  • erlotinib hydrochloride
  • +5 more
  • Cleveland, Ohio
    Case Western Reserve University
Jun 5, 2014

Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell

Completed
  • Recurrent Squamous Cell Carcinoma of the Hypopharynx
  • +24 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
May 7, 2014

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +38 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 2, 2014

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +33 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Feb 26, 2013

Anaplastic Thyroid Cancer, Insular Thyroid Cancer, Metastatic Parathyroid Cancer Trial in San Antonio (gefitinib)

Completed
  • Anaplastic Thyroid Cancer
  • +85 more
  • San Antonio, Texas
    Southwest Oncology Group
Jan 11, 2013

Recurrent NSCLC, Recurrent Ovarian Epithelial Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx Trial in Chicago

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +29 more
  • erlotinib hydrochloride
  • +3 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 8, 2013